Is Nexsen Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Nexsen Ltd (NXN.AX) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Nexsen Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Nexsen Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Nexsen Ltd?

Muslim investors may consider investing in Nexsen Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Nexsen Ltd classified as NOT COVERED?

Musaffa determines the Shariah status of Nexsen Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Nexsen Ltd updated?

The Shariah compliance status of Nexsen Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Nexsen Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Nexsen Ltd?

You can check the latest Shariah compliance status of Nexsen Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Nexsen Ltd. Stock Analysis NXN.AX

Australia Health Care Nano Cap

Nexsen Ltd. operates as a nano-biotechnology company, which develops lab-quality diagnostics and sensors. The company is headquartered in Melbourne, Victoria. The company went IPO on 2025-10-14. The firm is focused on development of proprietary biosensing platforms for rapid, high precision point-of-care (POC) medical diagnostics and point-of-use sensing for veterinary, agricultural and biosecurity applications. Its product pipeline includes GBS Rapid Sensor, Chronic kidney disease, and bovine mastitis. Its lead product, the GBS Rapid Sensor, is a diagnostic for the detection of human Group B Streptococcus (GBS) in expectant mothers. The firm is also developing a paper-based chronic kidney disease (CKD) test designed for early detection and routine monitoring across both clinics and at-home use. The bovine mastitis test is designed to test bovine mastitis in cows.

Key Statistics of Nexsen Ltd (NXN.AX)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

AUD0.23AUD0.24

Today's Open

AUD0.23

Volume

76.55K

P/E Ratio (TTM)

52 Week Range

AUD0.14AUD0.25

Market Cap

17.63M

Avg. Volume

Dividend Yield

Financial Metrics & Statements of Nexsen Ltd (NXN.AX)

FAQ's for Nexsen Ltd (NXN.AX)

According to Musaffa’s Shariah screening methodology, Nexsen Ltd (NXN.AX) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.